Annual General Meeting. The Annual General Meeting was held on May 4, 2012 at the Palais des Congrès (Paris)

Find Sanofi US corporate information, pharmaceutical products, news, career opportunities and health resources.

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, the world's fourth-largest by prescription sales. Sanofi engages in the ...

Welcome to sanofi pasteur in the U.S., Sanofi Pasteur, the vaccines division of sanofi-aventis Group, is the largest company in the world devoted entirely to human ...

Our products As a diversified global healthcare leader, Sanofi pursue new therapeutic solutions and propose products that respond to the needs of patients.

Sanofi career and job seeker information with job search, resume submission, career event fairs and expo appearances, company diversity, values, rewards and FAQs.

Sanofi pharmaceutical research, development, careers and product information for pharmaceuticals, cardiovascular, thrombosis, oncology, internal medicine, metabolic ...

Rapport Annuel 2011. Découvrez le nouveau site du Rapport Annuel Sanofi : activités, performances et faits marquants 2011

Type: Public On the web: http://www.sanofi.com Employees: 113,719 Employee growth: 12.0%; Sanofi is out to make all the world's creatures a little healthier.

Real-time prices for U.S.-listed stocks, including premarket and after hours, reflect trading through Nasdaq only. Comprehensive quotes reflect trading on ...

Sanofi (SNY) has not reported a lot of good news lately. The company plans to shut down a plant in Newcastle, and a drug that it has been working on has not received the approval for which the company had hoped. The company's factory in Tyneside, will not ...

Sanofi (SNY) plans to start laying off factory workers and will eventually shut down its Kansas City manufacturing plant at 10236 Marion Park Drive. The plant will be closed by August 2016. However, this is four years later than the company originally ...

The FINANCIAL -- Sanofi announced abstracts spanning the company’s innovative marketed and late-stage development compounds will be featured at the 2012 American Society of Clinical Oncology Annual Meeting in Chicago, Ill., June 1-5. Sanofi products are ...

May 15 (Bloomberg) -- Amylin Pharmaceuticals Inc. has lured suitors such as Pfizer Inc., AstraZeneca Plc and Sanofi, which signed confidentiality agreements on the drugmaker's sale process, said people familiar with the matter. Merck & Co ...

As the founding sponsor of the Sanofi BioGENEius Challenge Canada, a biotech competition where high school students are mentored by local scientists, I am a strong advocate of the potential of our youth to truly change our world. For example ...

We currently have low visibility on the status of Osiris' development and commercialization agreement with Genzyme, a Sanofi ( SNY) company, for Prochymal. Earlier this year, Sanofi, in its fourth quarter press release, had said that it has ...

A former Sanofi (SAN) research chemist was sentenced to 18 months in prison for stealing company trade secrets and making them available for sale through the U.S. unit of a Chinese company. Yuan Li, 30, was sentenced today in federal court in ...

Law360, New York (May 21, 2012, 2:05 PM ET) -- Bristol-Myers Squibb Co. and Sanofi-Aventis US LLC on Friday urged a judge to toss a suit accusing the drugmakers of deceptively marketing their blockbuster blood thinner Plavix and causing patients to overpay ...

Osiris, based in Columbia, Md., was developing Prochymal and a second stem cell treatment, Chondrogen, as part of a partnership with Genzyme, a unit of French drugmaker Sanofi. But in February Sanofi said it discontinued late-stage testing of Prochymal.

Sanofi Pasteur, the vaccines division of leading global pharmaceutical company Sanofi, and Janssen Pharmaceutical Companies of Johnson & Johnson, are the generous lead sponsors of the Challenge. “The BioGENEius Challenge showcases high school ...